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Abstract. 
The  revised W.H.O.  guidelines for  malaria management in  endemic 
treatment  should  be  reserved  to  laboratory  confirmed  cases,  both  for  adults  and  children. 
Currently  the  most widely  used  tools  are  rapid  diagnostic  tests  (RDTs),  that  are  accurate  and 
reliable in diagnosing malaria infection. Howev
and RDTs may give positive results in febrile patients who have another cause of fever. Excessive 
reliance on RDTs may cause overlooking potentially severe non malarial febrile illnesses (NMFI) in 
these  cases.  In  countries  or  areas  where  transmission  intensity  remains  very  high,  fever 
management in children (especially in the rainy season) should probably remain presumptive, as a 
test-based  management  may  not  be  safe,  nor  cost  effective.  In  contrast,  i
transmission, including those targeted for malaria elimination, RDTs are a key resource to limit 
unnecessary  antimalarial  prescription  and  to  identify  pockets  of  infected  individuals.  Research 
should focus on very sensitive tools for 
management on the other, including biomarkers of clinical malaria and/or of alternative causes of 
fever.
Background.  Malaria  management  policies  in  most 
sub-Saharan  countries  traditionally  relied  on 
presumptive  diagnosis  without  laboratory 
confirmation,  basically  considering  any  fever  as 
malaria,  particularly  in  children,  being  the  m
vulnerable to acute malaria.
1 This was basically due to 
the lack of laboratory facilities at the peripheral level 
of the health system (Primary Health Care or P.H.C.). 
The diagnosis was then barely clinical, and while over 
treatment  was  an  obvious  consequence, the  rationale 
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The  revised W.H.O.  guidelines for  malaria management in  endemic  countries  recommend  that 
treatment  should  be  reserved  to  laboratory  confirmed  cases,  both  for  adults  and  children. 
Currently  the  most widely  used  tools  are  rapid  diagnostic  tests  (RDTs),  that  are  accurate  and 
reliable in diagnosing malaria infection. However, an infection is not necessarily a clinical malaria, 
and RDTs may give positive results in febrile patients who have another cause of fever. Excessive 
reliance on RDTs may cause overlooking potentially severe non malarial febrile illnesses (NMFI) in 
se  cases.  In  countries  or  areas  where  transmission  intensity  remains  very  high,  fever 
management in children (especially in the rainy season) should probably remain presumptive, as a 
based  management  may  not  be  safe,  nor  cost  effective.  In  contrast,  i
transmission, including those targeted for malaria elimination, RDTs are a key resource to limit 
unnecessary  antimalarial  prescription  and  to  identify  pockets  of  infected  individuals.  Research 
should focus on very sensitive tools for infection on one side, and on improved tools for clinical 
management on the other, including biomarkers of clinical malaria and/or of alternative causes of 
Malaria  management  policies  in  most 
Saharan  countries  traditionally  relied  on 
presumptive  diagnosis  without  laboratory 
confirmation,  basically  considering  any  fever  as 
malaria,  particularly  in  children,  being  the  most 
This was basically due to 
the lack of laboratory facilities at the peripheral level 
of the health system (Primary Health Care or P.H.C.). 
The diagnosis was then barely clinical, and while over 
treatment  was  an  obvious  consequence, the  rationale 
behind  such  empirical  management  was  the  need  to 
avoid  missing  possible  malaria  cases,  especially  in 
children,  with  potentially  fatal  consequences. 
Moreover, the treatment used in most countries until 
the beginning of the new millennium was chloroquine, 
a  cheap  and affordable  drug,  albeit  increasingly 
ineffective against Plasmodium falciparum
spread  of  selected  resistant  strains.  During  the  last 
decade,  the  new  antimalarial  Artemisinin  Combined 
Treatments  (ACT),  that  are  extraordinarily  effective 
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and RDTs may give positive results in febrile patients who have another cause of fever. Excessive 
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based  management  may  not  be  safe,  nor  cost  effective.  In  contrast,  in  countries  with  low  
transmission, including those targeted for malaria elimination, RDTs are a key resource to limit 
unnecessary  antimalarial  prescription  and  to  identify  pockets  of  infected  individuals.  Research 
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children,  with  potentially  fatal  consequences. 
Moreover, the treatment used in most countries until 
the beginning of the new millennium was chloroquine, 
affordable  drug,  albeit  increasingly 
Plasmodium falciparum due to the 
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but  also orders  of  magnitude  more  expensive,  have 
become  the  first  choice  for  P.  falciparum malaria 
almost  everywhere.
2 Presumptive  treatment  of  all 
fevers with ACT would no more seem a logical and 
affordable choice, not only for economic reasons, but 
also because it is feared that a massive use of the new 
drugs  might  induce  selection  and  diffusion  of 
artemisinin-resistant strains of  P. falciparum.  For this 
reason  the  WHO  policy  changed,  recommending 
restricting  antimalarial  treatment  to  laboratory 
confirmed cases.
2
Unfortunately,  the quality of malaria microscopy is 
far  from satisfactory in  most countries, especially in 
sub-Saharan Africa where most of malaria burden is 
concentrated.  Moreover, the availability of microscopy 
is  generally  restricted  to  hospitals  and  private 
laboratories,  while  health  centres  and  dispensaries 
generally lack any laboratory facility.
Rapid Diagnostic Tests (RDT) for malaria, based on 
antigen  detection,  were  the  potential  solution.  RDTs 
cannot be considered a new tool any more. The first 
tests, based on the detection of histidine rich protein 
(HRP-2)  antigen  of  P.  falciparum,  were  already 
commercially  available  at  the  beginning  of  the 
nineties,
3 though much too expensive to be introduced 
in  low  to  middle  income  countries  (LMIC).  They 
proved to be highly sensitive and specific, though with 
some  false  positives,  especially  in  patients  with  a 
positive rheumathoid arthritis test.
4 In following years, 
many new tests were developed, based either on HRP-
2 or on lactic dehydrogenase (p-LDH), some of them 
restricted to P. falciparum, others capable of detecting  
specific  antigens  of  the  other  malaria  species,  too. 
Initially developed as a potential tool for travellers to 
malaria  endemic  countries,  the  new  tools  were  then 
progressively introduced and tested in the field, while 
their  cost  tended  to  diminish  in  parallel  with  an 
increased  production  and  diffusion.  RDTs  were 
submitted to evaluation in many malarious countries,
5-
10 and were generally found to be accurate and cost –
effective  if  compared  to  the  previous,  presumptive 
malaria  diagnosis.  The  W.H.O.  then  recommended 
that, if and where microscopy was not available, RDTs 
should  be  obligatorily  used  in  case  of  suspected 
malaria,  and  treatment  should  be  restricted  to 
positives.
2 Initially, the new policy was indicated for 
older  (>  5  years)  chidren  and  adults,  while  the 
presumptive policy remained the recommended one for 
small children, on ground of a higher vulnerability to 
malaria. This empirical approach appeared reasonable. 
Missing a malaria diagnosis in an infant might be fatal, 
while  this  is  less  so,  at  least  in  high  transmission 
settings, for older children and adults. Moreover, as the 
ACT  dosage  is  related  to  the  patient  weight,  the 
treatment of an adult is considerably more expensive 
than that of a child, and is generally higher than the 
cost of a RDT, too, while this is not necessarily true for 
the paediatric dosage.  
Malaria infection versus malaria disease. Infection 
does not necessarily mean disease, and this is true for 
many  different  etiologies  and  potential  pathogens: 
viruses, bacteria, fungi, protozoa and helminths.  As far 
as  malaria  is  concerned,  the  infection  may  be 
characterised,  for  example,  by  the  persistence  of  P. 
vivax or P. ovale “hypnozoites” in the liver, where they 
remain totally harmless for months or even years, until 
they  eventually  cause  a  relapse,  reaching  again  the 
erythrocytes.
11 For  P.  falciparum  the  liver  stage  is 
limited  to  the  initial  invasion,  and  the  hypnozoite 
phenomenon does not occur.  P. falciparum infection 
means  the  presence  of  trophozoites  and  schizonts  in 
blood,  where  they  undergo  an  asexual  replication  in 
RBCs, eventually destroying them when the schizonts 
rupture,  liberating  new  merozoites  which  will  infect 
new RBCs. The crucial event is the schizont (including 
the host RBC)  rupture with the following delivery of 
substances  both  of  the  host  RBC  and  of  the 
plasmodium, which trigger cascades, largely mediated 
by several cytokines, responsible for the fever and the 
other  main  pathological  aspects  of  malaria.
12 The 
intensity of the erythrocitic cycle depends on several 
factors, the crucial one being the level of immunity of 
the  infected  subject  which  is  related  to  previous 
exposure (the so called “premunition”).
13 In areas with 
high  intensity  of  transmission,  acute  and  potentially 
fatal attacks are typical of infants and young children, 
while  older  children  and  adults  are  at  least  partially 
protected  by  premunition.  They  are  still  exposed  to 
malaria,  but  acute  attacks  are  less  frequent  and  less 
severe.  Moreover,  a  high  proportion  of  apparently 
healthy  subjects  are  carriers  of    malaria  parasites  in 
blood.
What  is  clinical  malaria?  How  to  define  malaria 
disease  as opposed to  simple  malaria infection? The 
most honest answer to this simple question would be, 
surprisingly enough: we don’t know.
Malaria disease: fever plus plasmodia in blood? For 
practical  purposes,  one  could  argue  that  clinical 
malaria is a fever (alone or with various combinations 
of  other  symptoms  and  signs)  with  presence  of 
plasmodia in blood. Unfortunately, what is simple is 
not always true.
In  a  rural  health  centre  of  Banfora  province,  in 
Burkina Faso, during the dry season, a 2-year-old boy 
is  admitted  because  of  high  fever,  polypnoea  and  a 
visible, general prostration. The nurse in charge acts 
quickly: a malaria RDT is immediately performed and 
the result is positive. The child is immediately put on Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
intravenous quinine drip.  Unfortunately, the situation 
worsens in a few hours and the child dies the following 
morning.
Was there anything wrong in the case management? 
The  nurse  strictly  followed  the  local  guidelines,  and 
i.v.  artesunate  was  not  yet  available  at  the  time. 
Clearly, a child may die of severe malaria, even if the 
management is appropriate, as in our case. But are we 
really sure that the child actually had malaria? 
In  endemic  countries,  the  proportion  of  children 
who  are  carriers  of  malaria  parasites  in  blood  is 
variable, depending on the transmission intensity and 
the  season,  and  may  well  be  over  50%  in  some 
situations.
14,15  This  means that a child (or an adult) 
may have malaria infection despite the absence of any 
obvious symptom of disease, including fever.  Suppose 
now that this child gets a pneumonia, or  a typhoid, or a 
meningitis:  what  happens  to  malaria  parasites?  Will 
they disappear from the blood? Certainly not, although 
a  transient  decrease  in  parasite  density  may  occur.
16
This  child  will  have  fever  plus  malaria  parasites  in 
blood, and if submitted to a malaria test the result will 
be positive (and a true positive for that matter): yet, 
this child will NOT have clinical malaria, and if I am 
guided by the test result I can make a fatal mistake.
Then,  is  malaria  disease  a  fever  with  malaria 
infection at high parasite density?  The parasite density 
is the number of malaria parasites in the circulation, 
which is usually expressed per µL (or as percentage of 
infected RBC) and is usually estimated by microscopy 
by examining the thick film until we have counted 200 
WBC, and all the infected RBC that we detect in the 
same microscopic fields.
17 This is a rough estimate of 
course, moreover in severe infection schizonts tend to 
be sequestrated in the spleen, the liver, the brain and 
other internal organs and therefore a very high parasite 
burden  may  not  be  mirrored  in  the  peripheral 
circulation.  
It is certainly true that patients with clinical malaria 
tend  to  have  a  higher  parasite  density  than  subjects 
with a simple malaria infection, and there is no doubt 
that a patient with high fever and a 5% parasite density 
(or,  say,  >200,000  per  µL)  most  probably  HAS  a 
clinical  malaria.  But  what about  a  patient  with  high 
fever  and  a  lower  parasite  density?  May  I  exclude 
clinical malaria? Certainly not. This patient might also 
have clinical malaria, OR he may be a simple carrier of 
malaria  parasites  with  another  actual  cause  of  fever. 
How do I know? 
Malaria disease: fever plus plasmodia in blood plus 
other typical symptoms? Researchers have struggled 
to  find  clinical  signs  and  symptoms  that  are  good 
predictors  or  excluders  of  clinical  malaria. 
Unfortunately, the results have been frustrating. Some 
symptoms  such  as  vomiting  may  increase  the 
probability  of  malaria  in  children,  while  other 
symptoms  like  cough  may  decrease  that  probability, 
but no symptom combination can actually confirm or 
rule out the suspicion of malaria in a febrile child.
18
Malaria  attributable  fever:  an  epidemiological 
concept. Researchers assessing the efficacy of malaria 
vaccines  were  confronted  with  the  lack  of  a  case 
definition  of  clinical  malaria.  In  order  to  define  the 
vaccine efficacy, simple malaria infection is not a good 
indicator: pragmatically, they are not really interested 
in how many infections are prevented by a vaccine, but 
rather  in  how  many  disease  episodes  (and  related 
deaths)  are  potentially  avoided  by  vaccination. 
Therefore, in order to find a proxy of clinical malaria, 
the epidemiologists involved in vaccine trials focused 
on  fever,  and  attempted  at  estimating,  in  a  given 
population,  what  proportion  of  fevers  could  be 
attributed to malaria.
16 The basic concept was the well 
known epidemiological concept of the attributable risk 
(AR),  or  attributable  fraction  (AF),  that  aims  at 
estimating, in a longitudinal or in a case-control study, 
how many cases of a given disease are attributable to 
one or more risk factors. The formulas are well known 
and  may  be  retrieved  in  any  epidemiological 
textbook.
19    We  briefly summarize how  this  is  done 
starting  from  longitudinal  data,  that  is,  from  two 
populations of infected and not infected children and 
assessing the proportion of fevers occurring in a short 
time in the two groups.
20  If we call fp the proportion of 
febrile  amongst  parasitaemic  children,  and  fp0 the 
proportion of febrile children amongst aparasitaemiac 
children,  then  the  AF (or  the  proportion  of  fevers 
attributable to malaria) will be:
AF=(fp - fp0)/fp
The following example (Table 1) is taken from a 
population  study  in  children  in  the  Gambia.
21 More 
parasitaemic  than  aparasitaemic  children  have  fever 
(41/127 or 32% versus 33/280 or 11%).  But among the 
41 febrile patients with malaria parasites in blood, the 
fever is not caused by malaria in all, as fever is also 
found  in  a  (albeit  smaller)  proportion  of  uninfected 
children. The proportion of fevers that are attributable 
to malaria is represented by the AF.
fp =0.32 or 32% 
fp0=0.11 or 11%.
AF = (0.32 - 0.11)/0.32 = 0.63.
In normal language this means that 63% of children 
with fever and parasites are presumed to be ill due to 
malaria, in the other 37% the fever is probably caused Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
Table  1.  Presence  of  fever  according  to  parasitaemia  in  a 
population study.
fever no fever total
any parasite 41 86 127
no parasite 33 247 280
total 74 333 407
by  another  disease  (see  Figure  1 for  a  visual
representation).
In a given endemic area, only a proportion of fevers 
among infected subjects is attributable to malaria. This 
proportion increases with parasite density, and over a 
given  cut-off,  virtually  all  fevers  are  attributable  to 
malaria. The trouble is that this proportion is variable 
and depends on several factors, including the intensity 
of transmission, usually influenced by season and often 
variable  across  the  years,  and  on  the  age  of  the 
subjects.  Moreover,  the  AF  is  an  epidemiological 
concept  that  cannot  be  automatically  translated  into 
individual diagnosis. In a rural area of Burkina Faso, 
we estimated that in the rainy season, among children > 
5 years with fever and with a P. falciparum parasite 
density  between  400  and  4000/µL,  about  half  cases 
were  attributable  to  malaria.
22 If  I  see  an  individual 
patient with fever, and with a positive malaria film for 
P.falciparum, with parasite density say 2000/µL, what 
I can say is that my patient is about 50% likely to have 
an acute malaria attack, and 50% likely to be a carrier 
of malaria parasites in blood with another cause of his 
current fever. 
Malaria  infection  without  disease:  plasmodia  in 
blood  without  fever? Is  asymptomatic  malaria 
infection a harmless condition? Can we define infected 
subjects without fever as healthy carriers? The answer 
is no. Unfortunately, not much research has been done 
on the pathological effects of the long term presence of 
malaria infection in blood, but a strong epidemiological 
evidence  exists  that  malaria  infection  produces 
pathological  effects  even  in  the  absence  of  fever. 
Anemia is  certainly more frequent/severe in  children 
with  malaria  parasites  in  blood,  and  so  is 
splenomegaly,
23 to  such  an extent  that  the  so  called 
“spleen rate” is a marker of malaria prevalence that is 
almost as accurate as a lab based survey.
24 Anemia and 
a  big  spleen  are  the  most  common  markers  of  a 
“chronic malaria”, and these subjects cannot be defined 
as “healthy”. The most severe form of chronic malaria 
is  hyper-reactive  malarial  splenomegaly  (HMS),  a
Figure 1. Grafic representation of the attributable fraction (AF) of fever to malaria infection, based on data in Table 1. The area of the 
squares is proportional to the size of each group. Fevers attributable to malaria (in red) are only a proportion of infected subjects with fever, 
while in yellow are represented fevers likely to be due to another cause, albeit some are observed in plasmodia carriers.Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
neglected  condition  characterized  by  gross 
splenomegaly, pancytopenia, and a severely impaired 
cellular  immunity.
25 Plasmodia  are  present  in  blood, 
but  at  such a  low  parasite density that  they  may  be 
missed,  both  by  microscopy  and  by  RDTs.  This 
condition is invariably fatal if not adequately treated, 
and is probably the tip of the iceberg of the pathologic 
manifestations  of  a  chronic  malaria  infection.  A 
striking,  indirect  epidemiological  indication  of  the 
harmful effects of malaria infection is the spectacular 
reduction of child mortality observed by some of the 
first trials of impregnated bed nets:
26 the prevention of 
specific malaria mortality explained only a fraction of 
this  reduction,  indicating  that  malaria  infection  is  a 
predisposing  factor  to  death  from  other  causes. 
Therefore,  malaria  infection  is  likely  to  produce 
pathological effects even in the absence of fever, and 
when it is detected, it should probably be treated. 
Diagnosis  of  malaria  infection  and  disease. 
Microscopy is still the gold standard for the diagnosis 
of  malaria  infection.  The  technique  of  slide 
preparation, staining and reading are well known and 
standardized,  and  so  is  the  estimate  of  the  parasite 
density, which is an added value of microscopy and 
that can easily be estimated on a thick film (Figure 
2).
17 RDTs  are  now  replacing  microscopy  almost 
everywhere in endemic countries at P.H.C. level. A lot 
of different tests are available on the market and their 
accuracy  is  being  systematically  evaluated  by  the 
W.H.O.  in  partnership  with  other  organizations.
27,28
Several RDTs, both based on HRP-2 and on p-LDH, 
are  virtually  100% sensitive  at  a  comparatively  low 
parasite  density  (200  parasites/µL),  and  also  highly 
specific for P. falciparum malaria infection, some of 
them also for other plasmodia.
Other  diagnostic  methods  do  exist,  such  as  the 
Quantitative Buffy Coat (QBC) and polymerase chain 
reaction (PCR), but they require adequate laboratory
Figure 2. Giemsa stained thick film with high parasite density of P. 
falciparum (Photograph by Maria Gobbo, CTD Negrar)
facilities  and  are  not  an  option  for  routine  use  in 
endemic areas.
For practical purposes, RDTs are presently the main 
tool for the diagnosis of malaria in the field.  
In immunochromatographic RDTs, malaria antigen 
is captured by monoclonal antibodies conjugated to a 
dye in a strip of nitrocellulose, causing a clearly visible 
line to appear. Most tests have a control line, that is the 
only one that appears in a negative test (Figure 3, a), 
while in the positive test a second line appears (Figure 
3, b), usually within 15 minutes or less, making the 
reading straigthforward and reproducible, contrarily to 
microscopy. This is therefore an ideal tool in the field.
The systematic use of RDTs, now recommended by 
the WHO both for children and adults,
29 should limit 
the  prescription  of  antimalarials  to  those  who  really 
need it, thus diminishing the costs of malaria control 
programmes and preserving the efficacy of artemisinin-
based  drug  combinations.  Moreover,  by  excluding 
malaria as the cause of fever in RDT-negative subjects, 
health  workers  should  take  into  account  alternative 
causes of fever, also considering that in many countries 
malaria  incidence  has  sharply  declined  and  only  a 
small proportion of all fevers are due to malaria.
30-33
The new WHO policy has been preceded by a quite 
hot debate in the malaria community,
34,35 and has been 
largely based on convincing results in countries where 
the decrease in malaria incidence had been dramatic, 
such as in Tanzania.
36,37   
The extension of this policy to countries where this 
decline has not yet occurred is questionable, though.
Accuracy  and  cost  effectiveness  of  RDTs  for  the 
diagnosis  of  malaria  infection  and  of  malaria-
attributable fever. RDTs are an accurate tool for the 
diagnosis  of  malaria  infection.
5-10,20,25,26 Their 
sensitivity is sufficiently high to rule out malaria as the 
cause of fever in most instances, as they only miss very 
low parasite densities that are generally of no clinical 
Figure 3. HRP-2 – based RDT with positive (a) and negative (b) 
result (Photograph by Maria Gobbo, CTD Negrar)Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
significance.  Nevertheless,  in  infants  and  young 
children the proportion of fevers attributable to malaria 
is very high even at the lowest parasite densities, that 
may  be  missed  by  RDTs.
20,38 Moreover,  in  rare 
occasions, even a high  or very high  parasite  density 
may be missed by a RDT, due to the so-called prozone 
effect
39 or  to  other  reasons.  However,  in  general, 
refraining from malaria treatment in case of a negative 
RDT appears to be reasonably safe.
35  Specificity is a 
more complex matter. It has been assessed by many 
studies on malaria infection and generally found to be 
very high, meaning that when a RDT result is positive, 
plasmodia are in fact present in the blood. However, 
contrarily  to  traditional  microscopy,  RDTs  do  not 
provide any estimate of the parasite density, and their 
specificity  for  malaria-attributable  fever  is  highly 
variable,  being  very  low  in  some  epidemiological 
contexts.
20 This means in practical terms that a patient 
with fever AND a positive RDT can have malaria, OR 
an  alternative  cause  of  fever.  Prior  to  RDT 
introduction,  clinical  officers,  who  are  most  often 
nurses  at  the  peripheral  level  of  endemic  countries, 
used diagnostic algorithms based on clinical symptoms 
and signs only, and they often treated a febrile patient 
with both an antimalarial and an antibiotic if malaria 
and a bacterial fever were both possible, according to 
their  judgement.  The  use  of  RDTs  should  limit  this 
“double  prescription”  by  treating  only  with 
antimalarials those with a positive test, and with only 
antibiotics  those  who  test  negative  for  malaria,  and 
have  symptoms  and  signs  indicating  a  possible 
bacterial cause. 
While the latter option is probably reasonably safe, 
the former one is not. If a child with a fever due, say, to 
pneumonia is tested, and the RDT result is positive, the 
nurse may be suggested to treat only for malaria, while 
on clinical grounds he/she would have probably treated 
with both options. 
As  far  as  cost  effectiveness  is  concerned,  most 
studies  have  concluded  that  a  RDT-based  malaria 
management policy is cost-effective if compared to the 
presumptive management.
40-47 However, a major flaw 
of most of these studies was the implicit assumption 
health workers would fully adhere to the (negative) test 
result, while at least in some countries it was clearly 
shown that a high proportion of febrile patients testing 
negative  were  nevertheless  treated  for  malaria.
48,49  
Other  researchers  found  more  encouraging  results, 
however  in  contexts  where  malaria  incidence  had 
dropped.
34,50 Where and when malaria incidence is still 
high,  such  as  in  most  of  West  Africa  in  the  rainy 
season, a RDT-based policy was shown to be less cost-
effective  than  the  presumptive  approach,  and 
potentially  harmful,  especially  for  the  possible 
consequences of a false positive result on the antibiotic 
prescription for non malarial febrile illnesses.
51
A further limitation to cost-effectiveness of RDTs is 
the general tendency of using them on patients without 
fever, too,
48,52  causing a waste of resources. Moreover, 
although we have seen that malaria infection without 
fever is not necessarily harmless, extending the use of 
antimalarials  to  afebrile  patients  would  increase  the 
risk of selection of drug resistant strains, that is exactly 
what the test-based policy should limit, instead. 
An  evidence-based  approach  to  malaria  diagnosis 
and  management.  Malaria  management  policies 
cannot  be  the  same  everywhere,  regardless  the 
epidemiological  context.  Where  malaria  incidence  is 
(or has become) low or very low, RDTs have clearly a 
key role in limiting unnecessary malaria prescriptions. 
Refraining from malaria treatment in such contexts is 
most  probably  safe.
34,35 Health  workers  should 
however be properly trained on how to deal with the 
positive result: if the clinical picture is suggestive of a
possible  bacterial cause  of  fever,  a  double  treatment 
(antimalarial plus antibiotic) is justified, as a positive 
RDT  might  be  a  false  positive  in  clinical  terms,  by 
detecting  malaria infection  in  a  patient  who  actually 
has  another  acute  disease.  Clinical  guidelines, 
including  the  Integrated  Management  of  Childhood 
Ilnesses  (IMCI),  should  introduce  RDTs  at  the  right 
step. The node on treatment decision for NMFI should 
come before the RDT node in clinical algorithms, and 
the RDT result should be used as a guide for malaria 
treatment, but not to exclude other potential causes of 
fever.
49
In  countries  targeted  for  malaria  elimination,
53
RDTs and, potentially, new and even more sensitive 
diagnostic tools, may also be useful to identify pockets 
of  infected  people,  regardless  the  presence  of  fever, 
and  treat  them,  both  to  their  benefit  and  that  of  the 
community.
54
In contrast, in countries, or areas within countries, 
where  malaria is  still  hyperendemic  or  holoendemic, 
the  presumptive,  clinical  approach  should  be 
maintained, at least for children, and RDTs should not 
be used. For example, in a recent study in Burkina Faso 
during the rainy season, it was found that almost 90% 
of febrile children had a positive RDT.
20 The device 
tested was Paracheck® Device, that is not one of the 
most  sensitive  RDTs  according  to  W.H.O. 
assessment.
25,26 With  a  more  sensitive  test  the 
percentage  of  positive  results  would  have  probably 
approached  100%,  making  it  totally  useless  as  a 
decisional tool. It is clear that in such a situation using 
the test would only add the unnecessary costs of the 
test to that of the treatment, that would be administered 
to febrile children anyway.  Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
Diagnosing  imported  malaria  in  non  endemic 
countries.  What  might  be  a  correct  approach  for 
suspected imported malaria in a non endemic country? 
In this field of medicine, except for patients recently 
immigrating  from  holo-endemic  countries,  malaria 
infection  equals  malaria  disease.  Here  unlimited 
diagnostic  and  therapeutical  means  are  the  rule. 
Comparison  between  different  diagnostic  tools  is 
difficult:  if  microscopy  remains  the  gold  standard 
(reference  test),  the  judgment  will  depend  on  how 
many fields  have been examined.  Currently more or 
less 100 high magnification fields are standard, but in 
some  cases  a  diagnosis  is  made  after  careful 
scrutinizing a thick film during one or two hours, to 
find  finally only  one  parasite! This,  especially when 
P.ovale is at  stake, or when a treatment,  even a not 
specific one, e.g. with an antibiotic with antimalarial 
action such as cotrimoxazole, has already been started. 
PCR  is  highly  sensitive,  but  will  probably  not 
outperform this lengthy microscopical search. A multi 
centre diagnostic study carried out by GISPI network  
in Italy confirmed that expert microscopy still remains 
the mainstay of the diagnosis of imported malaria, and 
this,  particularly  in  mixed  or  in  non  falciparum 
infections,  where  it  still  outperforms  alternative 
methods, including PCR.
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However, advanced diagnostic tools and expertise 
are  not  necessarily  available  in  all  care  centers.  In 
peripheral  centers  PCR  is  not  available,  and  lab 
technicians  lack  expertise  in  microscopy.  Moreover, 
malaria  treatment  should  be  initiated  as  soon  as 
possible; diagnosis cannot wait until the next morning. 
As  a  consequence,  RDTs  have  a  substantial  role  in 
imported  malaria:  they  are  easy  to  perform,  recent 
brands  distinguish  between  falciparum  and  non 
falciparum,  they  have  a  sensitivity  high  enough  to 
exclude  a  clinically  important,  imminent  life 
threatening, falciparum infection. A further advantage 
is that a recent treatment does not necessarily hamper 
RDT sensitivity. National quality control of accuracy, 
compared  to  thick  film  simultaneously  taken,  is 
imperative since many caveats exist for correct use and 
interpretation. 
Conclusions  and  research  needs.  In  an  expert 
meeting at the European Commission DG research in 
2010,
56 experts  were  asked  what  the  most  relevant 
research needs on malaria diagnostics were. The basic 
conclusion was that we have already good tools for the 
diagnosis of malaria infection. However, in the context 
of  malaria  elimination  programmes,  research  should 
focus on the development of even more sensitive tools, 
and  ones  that  are  able  to  detect  also  asymptomatic 
carriers (of gametocytes and not only asexual forms), 
thus  contributing  to  detect  pocket  of  infected 
individuals  that  can  be  successfully  treated.
57 For 
clinical  management  however,  existing  tools  are 
already enough sensitive, as they are able to detect the 
vast  majority  of  malaria-attributable  fevers.  The 
problem is the lack of specificity for clinical malaria, 
especially  in  high  transmission  settings.  An  ideal 
diagnostic tool would detect malaria infection as well 
as identify biomarkers of clinically significant malaria 
(capable  of  distinguishing  disease  from  simple 
infection).  Potential  biomarkers  have  already  been 
identified. In addition, an improved RDT for malaria 
would be able to give a semi-quantitative assessment of 
the  parasite  density.  Alternatively,  research  should 
focus on incorporating in the same device markers of 
more than one disease, for example with the addition of 
a biomarker of bacterial disease to a malaria RDT. 
One may wonder, though, if excessive reliance in 
new technology will not cause the definitive abandon 
of basic, microscopy-based laboratory in the field, that 
could  still  be  an  invaluable  tool  not  only  for  the 
diagnosis of malaria, but also of TB, meningitis  and 
other  diseases,  provided  that  adequate  training, 
supervision and quality control are ensured.
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